|
|
Article: 47 of Early-Stage Pharmaceutical Marketing Budgets Dedicated to Working With Thought Leaders.
- Article from:
- PR Newswire
- Article date:
- March 20, 2007
|
Copyright informationCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., March 20 /PRNewswire/ -- Drug companies spend an average of 37 of their drug's marketing budgets on thought leader development, programs and activities in the early development stages, according to a new report, "Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch" (http://www.earlystagemarketing.com/), published by business intelligence firm Cutting Edge Information.
According to the report, 37 of marketing dollars spent during the pre-clinical stage, Phase I, and Phase II development support thought leader programs and activities. An additional 10 of overall commercialization spending goes toward developing new ...
Related newspaper, magazine, and journal articles:
|
|
Article: Marketing budgets get the chop.(Trends)(Brief Article)
Brand Strategy;
August 1, 2003 ;
150 words
...Marketing budgets for Q2 2003 have been cut by 11%, the biggest drop since late 2001...Practitioners in Advertising (IPA). For the first time since Q3 2001, direct marketing budgets were revised downwards, by 4.4 %. Sales promotion also experienced...
|
|